Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
Karas Eric sold 25,000 Ars Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 12, 2026 · Filed Jun 12, 2026
On Jun 12, 2026, Karas Eric (Chief Commercial Officer) sold 25,000 Ars Pharmaceuticals, Inc. shares at US$10.00 for US$250K under a trading plan, leaving 12,176 shares. Filed Jun 12, 2026 (Form 4).
- Sold
- 25,000 shares
- Price
- US$10.00
- Value
- US$250K
- Holding after
- 12,176 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Option exercise | 25,000 | US$1.50 | 37,176 | Direct |
| Jun 12, 2026 | Common Stock | Sale | 25,000 | US$10.00 | 12,176 | Direct |
Source
Related
- Ars Pharmaceuticals, Inc.
- Karas Eric
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Form 4 · Fitzpatrick Alexander A · Jun 12, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026